Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | FAAH | O00519 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.50 |
| ▸ | HTR3B | O95264 | 1/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.50 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19281815 | 0.90 | FAAH (0.65) | KDM4EFAAHALDH1A1LMNAMAPK1 | |
| SCHEMBL12551055 | 0.88 | KDM4E (0.61) | KDM4EFAAHALDH1A1CYP3A4MAPK1 | |
| SCHEMBL15867073 | 0.87 | KDM4E (0.50) | KDM4EFAAHALDH1A1LMNAHTR3E | |
| SCHEMBL12551059 | 0.83 | KDM4E (0.56) | KDM4EFAAHALDH1A1LMNAALOX15 | |
| SCHEMBL12551051 | 0.83 | LTA4H (0.60) | KDM4EFAAHALDH1A1LMNAALOX15 | |
| SCHEMBL12551057 | 0.80 | KDM4E (0.53) | KDM4EFAAHALDH1A1CYP3A4MAPK1 | |
| Piperidine SCHEMBL17460237 | 0.79 | FAAH (0.54) | KDM4EFAAHALDH1A1HTR3EHTR3B | |
| SCHEMBL12551009 | 0.78 | CHKA (0.59) | KDM4EFAAHALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL4563378 | 0.78 | KDM4E (0.59) | KDM4EFAAHALDH1A1KMT2AMAPT | |
| SCHEMBL10001302 | 0.78 | KDM4E (0.59) | KDM4EALDH1A1LMNAADRB1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127254-A1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | claimed |
| US-5547727-A | RADIATION TRANSPARENT SUBSTRATE WITH RECORDING AND REFLECTION LAYERS WITH DYES OF CATIONIC AZOCYANINE DYES | EASTMAN KODAK COMPANY (US) | 1996-08-20 | — | — | US | claimed |
| EP-0717402-A2 | Optical recording elements having recording layers containing cationic azo dyes | EASTMAN KODAK COMPANY (US) | 1996-06-19 | — | — | EP | claimed |
| EP-4663182-A2 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT | Scent Science International Inc. (JP) | 2025-12-17 | — | — | EP | disclosed |
| CN-119345196-A | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2025-01-24 | — | — | CN | disclosed |
| CN-119112885-A | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2024-12-13 | — | — | CN | disclosed |
| CN-119015277-A | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2024-11-26 | — | — | CN | disclosed |
| US-20240382497-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2024-11-21 | — | — | US | disclosed |
| US-12076325-B2 | Prophylactic or therapeutic agent for hypoxic injury, ischaemia-reperfusion injury and inflammation, cell protection agent for transplantation, and bio-preservation agent | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2024-09-03 | — | — | US | disclosed |
| CN-111918649-B | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2024-07-30 | — | — | CN | disclosed |
| US-20230183595-A1 | WELL DEFINED LOW MOLECULAR WEIGHT DISPERSANT POLYMETHACRYLATES | THE LUBRIZOL CORPORATION (US) | 2023-06-15 | — | — | US | disclosed |
| EP-1478629-B1 | N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | PHARMACIA & UPJOHN CO LLC (US) | 2006-10-11 | — | — | EP | disclosed |
| US-20060115516-A1 | Copolymerizable methine and anthraquinone compounds and articles containing them | ADVANCED MEDICAL OPTICS, INC. | 2006-06-01 | — | — | US | disclosed |
| US-6919329-B2 | N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives | PHARMACIA & UPJOHN COMPANY (US) | 2005-07-19 | — | — | US | disclosed |
| EP-1478629-A1 | N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS | PHARMACIA & UPJOHN COMPANY (US) | 2004-11-24 | — | — | EP | disclosed |
| US-20040147760-A1 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-29 | — | — | US | disclosed |
| US-20040044052-A1 | N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives | PHARMACIA & UPJOHN COMPANY | 2004-03-04 | — | — | US | disclosed |
| WO-2003072553-A1 | N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATES AND THEIR USE AS ANTIBACTERIALS | PHARMACIA & UPJOHN COMPANY (US) | 2003-09-04 | — | — | WO | disclosed |
| US-5547727-A | RADIATION TRANSPARENT SUBSTRATE WITH RECORDING AND REFLECTION LAYERS WITH DYES OF CATIONIC AZOCYANINE DYES | EASTMAN KODAK COMPANY (US) | 1996-08-20 | — | — | US | disclosed |
| EP-0717402-A2 | Optical recording elements having recording layers containing cationic azo dyes | EASTMAN KODAK COMPANY (US) | 1996-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060115516-A1 | Copolymerizable methine and anthraquinone compounds and articles containing them | AAAS, IK, CYBA | KDM4E 273/4885FAAH 1406/4885ALDH1A1 868/4885 |
| US-20240382497-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT | TRPA1, TRPV1, TRPM8 | KDM4E 4841/4885FAAH 1826/4885ALDH1A1 335/4885 |
| US-12076325-B2 | Prophylactic or therapeutic agent for hypoxic injury, ischaemia-reperfusion injury and inflammation, cell protection agent for transplantation, and bio-preservation agent | TRPA1, TRPV1, TRPM8 | KDM4E 4841/4885FAAH 1826/4885ALDH1A1 335/4885 |
| US-20040147760-A1 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | OXA1L, AADAC, MT-ND5 | KDM4E 905/4885FAAH 2436/4885ALDH1A1 956/4885 |
| US-20040044052-A1 | N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives | OXA1L, AADAC, MT-ND5 | KDM4E 905/4885FAAH 2436/4885ALDH1A1 956/4885 |
| US-20220127254-A1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | KIT, TNNI3K, CILK1 | KDM4E 838/4885FAAH 4696/4885ALDH1A1 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.